Memuat…
The U.S. is seeking to further expand soybean sales to China despite strong existing growth in shipments. China's approval process for new biotech products is slow, and public opposition to GMOs remains strong.
A 100-day trade action plan includes a China review of eight pending U.S. biotech applications, two of them for soybean products.
Faster Chinese approval of GMO soybean traits would support export demand for U.S. beans, while continued delays keep a regulatory risk premium on the trade.
ecns.cn17 Mei 2017Setelah 696 peristiwa perdagangan bullish sebelumnya, Kedelai bergerak median +0,3% selama 5 sesi (54% lebih tinggi; separuh tengah -1,3% sampai +1,9%), dan +0,7% selama 20 sesi.
Pergerakan benchmark setiap komoditas dari penutupan terakhir sebelum peristiwa. Pembacaan historis menggabungkan peristiwa serupa di masa lalu; itu menggambarkan apa yang terjadi, bukan apa yang akan terjadi. Bukan nasihat investasi.
